应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06990 科伦博泰生物-B
未开盘 01-13 16:08:13
480.800
-8.200
-1.68%
最高
493.600
最低
471.600
成交量
65.71万
今开
489.800
昨收
489.000
日振幅
4.50%
总市值
1,121亿
流通市值
782.60亿
总股本
2.33亿
成交额
3.16亿
换手率
0.40%
流通股本
1.63亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 科伦博泰生物-B 01月13日卖空量成交5.9万股,卖空比例为9.17%
市场透视 · 01-13 16:30
每日卖空追踪 | 科伦博泰生物-B 01月13日卖空量成交5.9万股,卖空比例为9.17%
科伦博泰生物-B盘中异动 大幅下挫3.07%报474.000港元
市场透视 · 01-13 13:32
科伦博泰生物-B盘中异动 大幅下挫3.07%报474.000港元
中国力量在JPM大会的闪耀时刻:24家国产企业双线发力
药渡 · 01-12 16:36
中国力量在JPM大会的闪耀时刻:24家国产企业双线发力
每日卖空追踪 | 科伦博泰生物-B 01月12日卖空量成交12.98万股,卖空比例为23.28%
市场透视 · 01-12 16:30
每日卖空追踪 | 科伦博泰生物-B 01月12日卖空量成交12.98万股,卖空比例为23.28%
科伦博泰生物-B盘中异动 股价大涨3.27%报492.000港元
市场透视 · 01-12 09:33
科伦博泰生物-B盘中异动 股价大涨3.27%报492.000港元
每日卖空追踪 | 科伦博泰生物-B 01月09日卖空量成交4.74万股,卖空比例为7.72%
市场透视 · 01-09
每日卖空追踪 | 科伦博泰生物-B 01月09日卖空量成交4.74万股,卖空比例为7.72%
科伦博泰生物-B01月09日获主力加仓855.2万元
市场透视 · 01-09
科伦博泰生物-B01月09日获主力加仓855.2万元
科伦博泰生物-B(06990)终止认购本金额9.8亿元的中国银行结构性存款
智通财经 · 01-07
科伦博泰生物-B(06990)终止认购本金额9.8亿元的中国银行结构性存款
科伦博泰生物-B终止认购中银结构性存款II
美股速递 · 01-07
科伦博泰生物-B终止认购中银结构性存款II
每日卖空追踪 | 科伦博泰生物-B 01月07日卖空量成交10.81万股,卖空比例为8.4%
市场透视 · 01-07
每日卖空追踪 | 科伦博泰生物-B 01月07日卖空量成交10.81万股,卖空比例为8.4%
科伦博泰生物-B将出席第44届摩根大通医疗健康大会 分享业务进展与创新战略
美股速递 · 01-07
科伦博泰生物-B将出席第44届摩根大通医疗健康大会 分享业务进展与创新战略
科伦博泰生物-B(06990)认购理财产品
智通财经 · 01-06
科伦博泰生物-B(06990)认购理财产品
每日卖空追踪 | 科伦博泰生物-B 01月05日卖空量成交6.59万股,卖空比例为6.68%
市场透视 · 01-05
每日卖空追踪 | 科伦博泰生物-B 01月05日卖空量成交6.59万股,卖空比例为6.68%
科伦博泰生物-B(06990.HK)一度涨超6%
每日经济新闻 · 01-05
科伦博泰生物-B(06990.HK)一度涨超6%
科伦博泰生物-B(06990)核心产品TROP2 ADC芦康沙妥珠单抗(SAC-TMT)联合免疫疗法帕博利珠单抗一线治疗PD-L1阳性局部晚期或转移性非小细胞肺癌获NMPA突破性疗法认定
智通财经 · 01-05
科伦博泰生物-B(06990)核心产品TROP2 ADC芦康沙妥珠单抗(SAC-TMT)联合免疫疗法帕博利珠单抗一线治疗PD-L1阳性局部晚期或转移性非小细胞肺癌获NMPA突破性疗法认定
恒瑞、百济双雄挺进TOP20!翰森、博泰加速冲刺,11家中国药企入榜,药企市值TOP50大洗牌
E药经理人 · 01-04
恒瑞、百济双雄挺进TOP20!翰森、博泰加速冲刺,11家中国药企入榜,药企市值TOP50大洗牌
科伦博泰生物-B(06990):ITGB6 ADC SKB105新药临床试验申请获国家药品监督管理局批准
智通财经 · 01-04
科伦博泰生物-B(06990):ITGB6 ADC SKB105新药临床试验申请获国家药品监督管理局批准
新版国家医保目录今日起实施 科伦博泰生物-B(06990)三款创新药惠及患者
智通财经 · 01-01
新版国家医保目录今日起实施 科伦博泰生物-B(06990)三款创新药惠及患者
科伦博泰生物-B涨0.35% 股价突破400港元大关
市场透视 · 2025-12-31
科伦博泰生物-B涨0.35% 股价突破400港元大关
每日卖空追踪 | 科伦博泰生物-B 12月30日卖空量成交2.35万股,卖空比例为5.51%
市场透视 · 2025-12-30
每日卖空追踪 | 科伦博泰生物-B 12月30日卖空量成交2.35万股,卖空比例为5.51%
加载更多
公司概况
公司名称:
科伦博泰生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
四川科伦博泰生物医药股份有限公司是一家主要从事新药业务的研发、生产和销售的中国公司。该公司主要从事肿瘤学、免疫学及其他治疗领域的创新药物的研发、制造及商业化。该公司的产品为抗体药物偶联物(ADC)SKB264及A166。该公司产品主要用于乳腺癌、非小细胞肺癌、胃肠道癌等非肿瘤疾病的治疗。
发行价格:
--
{"stockData":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科伦博泰生物-B","latestPrice":480.8,"timestamp":1768291693006,"preClose":489,"halted":0,"volume":657118,"delay":0,"floatShares":162769979,"shares":233185969,"eps":-1.3463173732066378,"marketStatus":"未开盘","change":-8.2,"latestTime":"01-13 16:08:13","open":489.8,"high":493.6,"low":471.6,"amount":316059027,"amplitude":0.04499,"askPrice":480.8,"askSize":3100,"bidPrice":480.4,"bidSize":2700,"shortable":3,"etf":0,"ttmEps":-3.58194592061226,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":0,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":489,"openAndCloseTimeList":[[1768267800000,1768276800000],[1768280400000,1768291200000]],"volumeRatio":0.5678138306115046,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06990","defaultTab":"news","newsList":[{"id":"2603632617","title":"每日卖空追踪 | 科伦博泰生物-B 01月13日卖空量成交5.9万股,卖空比例为9.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603632617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603632617?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:30","pubTimestamp":1768293038,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月13日,跌1.68%,卖空量成交5.9万股,较上一交易日减少72.24%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113164637a714ffa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113164637a714ffa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2603326726","title":"科伦博泰生物-B盘中异动 大幅下挫3.07%报474.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603326726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603326726?lang=zh_cn&edition=full","pubTime":"2026-01-13 13:32","pubTimestamp":1768282374,"startTime":"0","endTime":"0","summary":"2026年01月13日下午盘13时32分,科伦博泰生物-B股票出现波动,股价急速下挫3.07%。截至发稿,该股报474.000港元/股,成交量38.9488万股,换手率0.24%,振幅3.80%。资金方面,该股资金流入7610.27万港元,流出6821.06万港元。科伦博泰生物-B股票所在的生物技术行业中,整体涨幅为1.46%。科伦博泰生物-B公司简介:四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113133255953c85f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113133255953c85f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2602902425","title":"中国力量在JPM大会的闪耀时刻:24家国产企业双线发力","url":"https://stock-news.laohu8.com/highlight/detail?id=2602902425","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602902425?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:36","pubTimestamp":1768206992,"startTime":"0","endTime":"0","summary":"而今年,中国力量成为舞台上最耀眼的星光之一:24家国产医药企业集体亮相,以“主会场引领、亚太专场扩容”的双线布局,向世界展示中国医药产业的创新硬实力与全球化野心。结 语从主会场的核心发声到亚太专场的集体亮相,24家中国药企在JPM大会的舞台上,用实打实的研发成果、商业化突破与海外合作,书写着中国医药的全球化篇章。这不仅是中国力量的闪耀时刻,更预示着2026年中国创新药将在全球舞台上迎来更多突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112165035a710cae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112165035a710cae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1770034418.SGD","01276","LU1251922891.USD","LU0588546209.SGD","LU1719994722.HKD","LU2328871848.SGD","BK1574","LU0307460666.USD","06978","06990","BK1500","BK1588","06160","02269","09688","LU1303224171.USD","LU1969619763.USD","LU2488822045.USD","01530","BK1583","BK1161","09995","02359"],"gpt_icon":0},{"id":"2602163215","title":"每日卖空追踪 | 科伦博泰生物-B 01月12日卖空量成交12.98万股,卖空比例为23.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602163215","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602163215?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:30","pubTimestamp":1768206636,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月12日,涨2.64%,卖空量成交12.98万股,较上一交易日增加40.02%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112165228a710ccc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112165228a710ccc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2602939795","title":"科伦博泰生物-B盘中异动 股价大涨3.27%报492.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602939795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602939795?lang=zh_cn&edition=full","pubTime":"2026-01-12 09:33","pubTimestamp":1768181616,"startTime":"0","endTime":"0","summary":"2026年01月12日早盘09时33分,科伦博泰生物-B股票出现波动,股价快速拉升3.27%。截至发稿,该股报492.000港元/股,成交量3.01万股,换手率0.02%,振幅3.44%。资金方面,该股资金流入918.184万港元,流出215.354万港元。科伦博泰生物-B股票所在的生物技术行业中,整体涨幅为1.69%。科伦博泰生物-B公司简介:四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112093338a70f6645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112093338a70f6645&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2602530390","title":"每日卖空追踪 | 科伦博泰生物-B 01月09日卖空量成交4.74万股,卖空比例为7.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602530390","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602530390?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:30","pubTimestamp":1767947438,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月09日,涨1.53%,卖空量成交4.74万股,较上一交易日减少71.15%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109164019a4af86cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109164019a4af86cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2602903303","title":"科伦博泰生物-B01月09日获主力加仓855.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602903303","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602903303?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:15","pubTimestamp":1767946548,"startTime":"0","endTime":"0","summary":"01月09日, 科伦博泰生物-B股价涨1.53%,报收476.40元,成交金额2.9亿元,换手率0.38%,振幅4.09%,量比0.54。科伦博泰生物-B今日主力资金净流入855.2万元,上一交易日主力净流入114.9万元。该股近5个交易日上涨19.67%,主力资金累计净流出4298.6万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2859.9万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109162146a7066a44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109162146a7066a44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2601804888","title":"科伦博泰生物-B(06990)终止认购本金额9.8亿元的中国银行结构性存款","url":"https://stock-news.laohu8.com/highlight/detail?id=2601804888","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601804888?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:49","pubTimestamp":1767797381,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科伦博泰生物-B(06990)发布公告,内容有关据中国银行结构性存款协议II认购本金额为人民币9.8亿元的中国银行结构性存款II。公司已于2026年1月7日终止该认购。由于此终止是在中国银行结构性存款协议II规定的投资冷静期内执行,本司无需就该认购支付任何款项,且不会因本次终止而产生任何其他费用或罚款。终止该认购乃经公司进一步考量后,对其理财策略作出调整所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390103.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1560","LU0651946864.USD","LU1515016050.SGD","BK0183","LU1634259391.SGD","LU0651947912.USD","LU2097828714.EUR","BK0012","LU1051768304.USD","LU1282651048.USD","LU1634259557.SGD","LU2097828474.EUR","LU1224444064.USD","BK1161","LU2097828805.USD","BK1231","LU1282651121.HKD","03988","LU0072462343.USD","LU1497733631.SGD","LU1051769294.HKD","LU1048588211.SGD","LU0293314216.USD","LU0307460666.USD","BK0015","BK0028","601988","LU1497734951.SGD","SG9999006597.SGD","LU2097828631.EUR","LU0196878994.USD","LU1522347837.USD","IE00BWDBJ730.SGD","SG9999001093.SGD","LU0588546209.SGD","BK1521","BK0188","LU0348805143.USD","IE00B19Z5X02.USD","03143","06990","BK0278","LU2097828557.USD","LU1497733557.USD","IE00BQJZWZ67.USD"],"gpt_icon":0},{"id":"1115040855","title":"科伦博泰生物-B终止认购中银结构性存款II","url":"https://stock-news.laohu8.com/highlight/detail?id=1115040855","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115040855?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:48","pubTimestamp":1767797292,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B(股票代码:06990)宣布,其先前认购的中银结构性存款II产品已正式终止。该决定基于公司资金管理策略的调整,旨在优化资金使用效率。公司表示将根据市场情况适时调整投资组合,确保资金安全与收益平衡。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2601345153","title":"每日卖空追踪 | 科伦博泰生物-B 01月07日卖空量成交10.81万股,卖空比例为8.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601345153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601345153?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:30","pubTimestamp":1767774639,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月07日,涨7.44%,卖空量成交10.81万股,较上一交易日减少2.44%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163616a4a6e8e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163616a4a6e8e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"1114861024","title":"科伦博泰生物-B将出席第44届摩根大通医疗健康大会 分享业务进展与创新战略","url":"https://stock-news.laohu8.com/highlight/detail?id=1114861024","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114861024?lang=zh_cn&edition=full","pubTime":"2026-01-07 10:49","pubTimestamp":1767754179,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B(股票代码:06990)确认将参与第44届摩根大通医疗健康大会。届时,公司将向全球投资者与行业伙伴详细介绍其最新业务发展成果及未来创新战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU2746668974.SGD","LU0868494708.USD","LU2552382058.USD","LU1720051017.SGD","IE00BDCRKT87.USD","LU0006306889.USD","LU0196878994.USD","LU2430703251.USD","LU0820562030.AUD","LU0211331839.USD","LU2430703178.SGD","LU1145028129.USD","LU0496365809.HKD","LU0211327993.USD","LU0265550359.USD","LU1894683348.USD","LU2237443549.SGD","BK4550","LU0106261372.USD","SG9999002232.USD","LU2264538146.SGD","IE00BHPRN162.USD","IE00BBT3K403.USD","LU0203347892.USD","BK4585","IE00B775SV38.USD","BK4534","LU1670627923.USD","BK4504","LU1496350171.SGD","LU2456880835.USD","IE00BLSP4452.SGD","LU0964807845.USD","LU0208291251.USD","BK4581","LU2592432038.USD","IE00BDRTCR15.USD","LU2756315318.SGD","LU2242649171.HKD","LU2023250504.SGD","IE00BLSP4239.USD","LU1720051108.HKD","LU1548497426.USD","LU0310799852.SGD","LU2211815571.USD","LU2756315664.SGD","LU1551013342.USD","IE00BJTD4N35.SGD","LU0345770308.USD","LU0345769631.USD","IE00BJTD4V19.USD","LU1914381329.SGD","LU0048584097.USD","IE0034235188.USD","LU0106831901.USD","LU0640476718.USD","LU2552382132.HKD","LU1261432733.SGD","LU1064131342.USD","LU0265550946.USD","LU0345770993.USD","LU0683600562.USD","LU0942090050.USD","LU2462157665.USD","LU1363072403.SGD","LU0238689110.USD","LU2023250843.SGD","IE0034235303.USD","IE00BN8TJ469.HKD","LU2505996681.GBP","IE00B1XK9C88.USD","IE00B1BXHZ80.USD","LU1116320901.HKD","BK4588","LU1162221912.USD","LU0868494617.USD","LU0787776722.HKD","LU0323591593.USD","LU0256863811.USD","BK4566","IE00BKDWB100.SGD","LU0267386448.USD","LU1084165304.USD","LU0211326755.USD","LU1119994496.HKD","BK1161","IE000M9KFDE8.USD","IE00BKVL7J92.USD","IE00BYXW3230.USD","LU1032466523.USD","LU2213496289.HKD","IE00BFXG1179.USD","LU1988902786.USD","LU1894683264.USD","LU1116320737.USD","LU1366192091.USD","LU2237443622.USD","LU0149725797.USD","LU2357305700.SGD","06990","LU1267930490.SGD","LU0070302665.USD","LU0320765646.SGD","LU1551013425.SGD","LU0215105999.USD","LU2237443465.HKD","LU1244550494.USD","LU1496350502.SGD","LU0976567544.SGD","LU0345769128.USD","LU2417539215.USD","IE00BJLML261.HKD","LU1244550221.USD","LU0320765489.SGD","LU0882574139.USD","LU2430703095.HKD","LU1670628061.USD","IE00BZ1G4Q59.USD","LU1629891620.HKD","LU2054465674.USD","LU2023250330.USD","LU0251132253.USD","LU1244550577.SGD","LU2746668461.USD","LU0211326839.USD","LU1974910355.USD","LU2381873111.SGD","LU2505996509.AUD","LU1280957306.USD","BK4533","LU2106854487.HKD","LU0170899867.USD","LU0689472784.USD","BK4516","BK4207","LU0211328371.USD","LU0971096721.USD","SG9999002224.SGD","IE00B3S45H60.SGD","LU0203345920.USD","LU2237443895.HKD","LU2236285917.USD","IE0034235295.USD","LU2552382215.SGD","LU0943347566.SGD","LU1668664300.SGD","LU0820561909.HKD","LU1917777945.USD","LU2237443382.USD","LU2237443978.SGD","IE00BWXC8680.SGD","LU0417517546.SGD","LU0820561818.USD"],"gpt_icon":0},{"id":"2601076892","title":"科伦博泰生物-B(06990)认购理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2601076892","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601076892?lang=zh_cn&edition=full","pubTime":"2026-01-06 20:56","pubTimestamp":1767704191,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科伦博泰生物-B(06990)发布公告,于2026年1月6日,公司订立中国银行结构性存款协议II,据此,公司同意认购本金额为人民币9.8亿元的中国银行结构性存款II。于2026年1月6日,公司订立交通银行结构性存款协议,据此,公司同意认购本金额为人民币4亿元的交通银行结构性存款。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2601889317","title":"每日卖空追踪 | 科伦博泰生物-B 01月05日卖空量成交6.59万股,卖空比例为6.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601889317","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601889317?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601837,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月05日,涨7.84%,卖空量成交6.59万股,较上一交易日增加58.41%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163743a49e2bee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163743a49e2bee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2601071680","title":"科伦博泰生物-B(06990.HK)一度涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601071680","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601071680?lang=zh_cn&edition=full","pubTime":"2026-01-05 11:04","pubTimestamp":1767582277,"startTime":"0","endTime":"0","summary":"每经AI快讯,科伦博泰生物-B(06990.HK)一度涨超6%,截至发稿涨5.89%,报427.2港元,成交额1.29亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601053608569551.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601053608569551.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2601020061","title":"科伦博泰生物-B(06990)核心产品TROP2 ADC芦康沙妥珠单抗(SAC-TMT)联合免疫疗法帕博利珠单抗一线治疗PD-L1阳性局部晚期或转移性非小细胞肺癌获NMPA突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2601020061","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601020061?lang=zh_cn&edition=full","pubTime":"2026-01-05 08:01","pubTimestamp":1767571299,"startTime":"0","endTime":"0","summary":"此前,公司公布了芦康沙妥珠单抗联合帕博利珠单抗一线治疗PD-L1阳性NSCLC的3期OptiTROP-Lung05临床试验结果,其在主要终点无进展生存期显示出统计学意义和临床意义的显著改善,并在总生存期方面观察到获益趋势。OptiTROP-Lung05研究是首个免疫联合ADC在一线治疗NSCLC上达到主要终点的3期临床研究。此次在一线治疗PD-L1阳性NSCLC获得突破性疗法认定,将为加速芦康沙妥珠单抗在此适应症审评与上市进程提供助力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388399.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4231","LU1169589451.USD","PD","06990","BK4023","LU0196878994.USD","LU1169590202.USD","ADC","BK4080"],"gpt_icon":0},{"id":"2601029158","title":"恒瑞、百济双雄挺进TOP20!翰森、博泰加速冲刺,11家中国药企入榜,药企市值TOP50大洗牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2601029158","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601029158?lang=zh_cn&edition=full","pubTime":"2026-01-04 21:09","pubTimestamp":1767532195,"startTime":"0","endTime":"0","summary":"2025年的全球药企市值TOP50榜单,不再是跨国巨头的独角戏,11家中国药企集体亮剑。从“还差临门一脚”到稳坐TOP20一隅如果将时间拨回到2023年,中国药企在全球市值TOP50中的处境,常被形容为还差“临门一脚”。而到了2025年末,中国药企在全球药企市值的排行已经发生了实质性改变。恒瑞在2025年中登陆港交所后,其在港股市值一度突破5000亿港元。首次冲进全球制药企业市值TOP20的百济,则代表着另一条路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104212120a6f20aa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104212120a6f20aa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1161","06990","06160","03692","LU0196878994.USD","01801","BK1583","BK1589","09926"],"gpt_icon":0},{"id":"2600040163","title":"科伦博泰生物-B(06990):ITGB6 ADC SKB105新药临床试验申请获国家药品监督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2600040163","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600040163?lang=zh_cn&edition=full","pubTime":"2026-01-04 19:59","pubTimestamp":1767527952,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科伦博泰生物-B 发布公告,公司自主研发的靶向整合素β6抗体偶联药物SKB105的新药临床试验申请已获中国国家药品监督管理局药品审评中心批准,用于治疗晚期实体瘤。公司计划于近期向中国国家药品监督管理局药品审评中心递交SKB118/CR-001的IND申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ADC","BK4231","06990","LU0196878994.USD","BK4080","BK1161"],"gpt_icon":0},{"id":"2600100700","title":"新版国家医保目录今日起实施 科伦博泰生物-B(06990)三款创新药惠及患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2600100700","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600100700?lang=zh_cn&edition=full","pubTime":"2026-01-01 09:03","pubTimestamp":1767229415,"startTime":"0","endTime":"0","summary":"在这份新目录中,科伦博泰生物-B自主研发的芦康沙妥珠单抗(佳泰莱)、西妥昔单抗N01(达泰莱)与塔戈利单抗(科泰莱)三款创新药物成功跻身其中。据悉,对于晚期三阴性乳腺癌患者及EGFR-TKI治疗失败的非小细胞肺癌患者而言,传统治疗手段往往收效甚微。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","LU0196878994.USD","159992","06990","BK1574","BK1161"],"gpt_icon":0},{"id":"2595414777","title":"科伦博泰生物-B涨0.35% 股价突破400港元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2595414777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595414777?lang=zh_cn&edition=full","pubTime":"2025-12-31 09:30","pubTimestamp":1767144618,"startTime":"0","endTime":"0","summary":"2025年12月31日早盘09时30分,科伦博泰生物-B股票出现波动,股价快速上涨0.35%。截至发稿,该股报400.600港元/股,成交量100股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出20.01万港元。科伦博泰生物-B股票所在的生物技术行业中,整体跌幅为0.55%。科伦博泰生物-B公司简介:四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025123109301897a0e0e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025123109301897a0e0e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2595715952","title":"每日卖空追踪 | 科伦博泰生物-B 12月30日卖空量成交2.35万股,卖空比例为5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595715952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595715952?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083437,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间12月30日,跌1.63%,卖空量成交2.35万股,较上一交易日减少51.14%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163631a6e07fc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163631a6e07fc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://kelun-biotech.com","stockEarnings":[{"period":"1week","weight":0.0902},{"period":"1month","weight":0.0962},{"period":"3month","weight":0.026},{"period":"6month","weight":0.2508},{"period":"1year","weight":1.8568},{"period":"ytd","weight":0.2259}],"compareEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.0336},{"period":"3month","weight":0.0362},{"period":"6month","weight":0.0959},{"period":"1year","weight":0.4225},{"period":"ytd","weight":0.0475}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"四川科伦博泰生物医药股份有限公司是一家主要从事新药业务的研发、生产和销售的中国公司。该公司主要从事肿瘤学、免疫学及其他治疗领域的创新药物的研发、制造及商业化。该公司的产品为抗体药物偶联物(ADC)SKB264及A166。该公司产品主要用于乳腺癌、非小细胞肺癌、胃肠道癌等非肿瘤疾病的治疗。","exchange":"SEHK","name":"科伦博泰生物-B","nameEN":"SKB BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科伦博泰生物-B(06990)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科伦博泰生物-B,06990,科伦博泰生物-B股票,科伦博泰生物-B股票老虎,科伦博泰生物-B股票老虎国际,科伦博泰生物-B行情,科伦博泰生物-B股票行情,科伦博泰生物-B股价,科伦博泰生物-B股市,科伦博泰生物-B股票价格,科伦博泰生物-B股票交易,科伦博泰生物-B股票购买,科伦博泰生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科伦博泰生物-B(06990)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}